Your browser doesn't support javascript.
loading
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
He, Kewen; Barsoumian, Hampartsoum B; Puebla-Osorio, Nahum; Hu, Yun; Sezen, Duygu; Wasley, Mark D; Bertolet, Genevieve; Zhang, Jie; Leuschner, Carola; Yang, Liangpeng; Kettlun Leyton, Claudia S; Fowlkes, Natalie Wall; Green, Morgan Maureen; Hettrick, Lisa; Chen, Dawei; Masrorpour, Fatemeh; Gu, Meidi; Maazi, Hadi; Revenko, Alexey S; Cortez, Maria Angelica; Welsh, James W.
Afiliação
  • He K; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China.
  • Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Puebla-Osorio N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hu Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sezen D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wasley MD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bertolet G; Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey.
  • Zhang J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Leuschner C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yang L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kettlun Leyton CS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fowlkes NW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Green MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hettrick L; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen D; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Masrorpour F; Ionis Pharmaceuticals, Carlsbad, California.
  • Gu M; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China.
  • Maazi H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Revenko AS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cortez MA; Ionis Pharmaceuticals, Carlsbad, California.
  • Welsh JW; Ionis Pharmaceuticals, Carlsbad, California.
Cancer Immunol Res ; 11(4): 486-500, 2023 04 03.
Article em En | MEDLINE | ID: mdl-36700864
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma Pulmonar de Lewis / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Carcinoma Pulmonar de Lewis / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article